Who
Christopher A. Kroeger
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, MapLight Therapeutics; Chief Executive Officer, Tempest Therapeutics.
In numbers
- Trades disclosed
- 74
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $25.7M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 10 May 2018
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $595K73,691 at $8.08 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —23,145 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,955 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,955 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —23,145 at $0.00 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $636K16,779 at $37.90 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $636K16,779 at $37.90 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.5M40,899 at $36.46 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.0M28,091 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,49292 at $37.96 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.5M40,899 at $36.46 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.0M28,091 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,49292 at $37.96 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $682K18,950 at $36.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.6M42,738 at $36.99 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,37990 at $37.54 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $682K18,950 at $36.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.6M42,738 at $36.99 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,37990 at $37.54 | filing |
| 18 May 2026filed 18 May 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $3.2M118,037 at $27.19 | filing |
News
No headline names them, or the companies they trade most, lately.